Norma Lynn Fox
- Molecular Biology top 10%
- Immunology top 5%
- Oncology top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Rheumatology top 2%
- Co-authors
- J. Richard HebelMary SextonA. CoreyDavid A. RothWendy HalpernJames GroarkMargaret von MehrenDavid Gordon
- Topics
- Cell death mechanisms and regulation (10 papers)Systemic Lupus Erythematosus Research (7 papers)Coronary Interventions and Diagnostics (5 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Norma Lynn Fox
32 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 117
- Molecular Biology 881
- Immunology 596
- Oncology 380
- Radiology, Nuclear Medicine and Imaging 357
- Rheumatology 354
Countries citing papers authored by Norma Lynn Fox
This map shows the geographic impact of Norma Lynn Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norma Lynn Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norma Lynn Fox more than expected).
Fields of papers citing papers by Norma Lynn Fox
This network shows the impact of papers produced by Norma Lynn Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norma Lynn Fox. The network helps show where Norma Lynn Fox may publish in the future.
Co-authorship network of co-authors of Norma Lynn Fox
This figure shows the co-authorship network connecting the top 25 collaborators of Norma Lynn Fox. A scholar is included among the top collaborators of Norma Lynn Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norma Lynn Fox. Norma Lynn Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 31 | |
| 3 | 26 | |
| 4 | 81 | |
| 5 | 85 | |
| 6 | 50 | |
| 7 | 198 | |
| 8 | A phase 1b study to assess the safety of lexatumumab, a human monoclonal antibody that activates TRAIL-R2, in combination with gemcitabine, pemetrexed, doxorubicin or FOLFIRI. | 33 |
| 9 | Development of sensitive and specific immunohistochemical assays for pro-apoptotic TRAIL-receptors | 6 |
| 10 | 9 | |
| 11 | 7 | |
| 12 | 2 | |
| 13 | 15 | |
| 14 | 41 | |
| 15 | 111 | |
| 16 | 26 | |
| 17 | 158 | |
| 18 | 71 | |
| 19 | 39 | |
| 20 | 123 |
About Norma Lynn Fox
Norma Lynn Fox is a scholar working on Internal Medicine, Rheumatology and Cardiology and Cardiovascular Medicine, having authored 33 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (10 papers), Systemic Lupus Erythematosus Research (7 papers) and Coronary Interventions and Diagnostics (5 papers). The work is most often cited by research in Immunology (596 citations), Internal Medicine (92 citations) and Rheumatology (354 citations). Norma Lynn Fox has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include J. Richard Hebel, Mary Sexton, A. Corey, David A. Roth, Wendy Halpern, James Groark, Margaret von Mehren, David Gordon, Anne E. Hammer and Roger B. Cohen. Their work appears in journals such as Circulation, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.